Joslin Diabetes Center Inc is a 501(c)(3) organization based in Boston, Massachusetts, registered in 1961, with $71,591,609 in FY2023 revenue. CharityIndex grades it B+, and it directs about 79% of spending to programs.
Revenue (FY2023)
$71.6M
▼ 3.5% vs prior year
Diseases median: $206K
Expenses (FY2023)
$81.6M
Net assets
$160.6M
Employees
407
Measures how much of every dollar spent actually reaches programs, plus what it costs to raise $100 of donations. The worse of the two measures sets the letter (85%+ to programs is an A; under $15 to raise $100 is an A), averaged over the three most recent filings. For Joslin Diabetes Center Inc: 79% to programs · $1 to raise $100 earns a B+ on this criterion. See the exact thresholds →
Measures whether the organization is built to last: how many months its reserves would cover expenses (3+ months earns an A-range score, but hoarding 5+ years of budget is capped) and whether it runs a surplus or a deficit. For Joslin Diabetes Center Inc: 24 mo reserves · -14% margin earns a C+ on this criterion. See the exact thresholds →
Checks how the organization is run, from its own Form 990: an independent board majority, a board of five or more, conflict-of-interest, whistleblower and document-retention policies, and independently audited financials. The share of disclosed checks that pass sets the letter. For Joslin Diabetes Center Inc: 6 of 6 checks met earns a A+ on this criterion. See the exact thresholds →
Counts five disclosure signals: a recent filing, a mission statement, program descriptions, a listed website, and the full expense breakdown. More disclosure, better letter. For Joslin Diabetes Center Inc: 5 of 5 disclosure signals earns a A+ on this criterion. See the exact thresholds →
Show this grade on your website
A live seal — it updates automatically when the grade changes and links donors to this verified profile.
Our mission is to prevent, treat, and cure diabetes. our vision is a world free of diabetes and its complications.
Research: joslin engages in research related to better understanding diabetes, how to treat it and how to help patients manage and live healthier lives with the disease. joslin diabetes research center is one of only 16 nih-designated diabetes research centers in the united states. joslin's research team is world-renowned and passionate about improving the lives of people with diabetesmillions of people with diabetes throughout the world benefit directly from basic and clinical research conducted at the center. approximately 300 researchers employed at the joslin diabetes center are working on various aspects of diabetes, searching for ways to prevent and treat diabetes in all its forms and ultimately find a cure for the disease.during the period covered by this filing, jdc had 100,426 patient encounters and 66,184 outpatient visits including, 29,705 adult diabetes visits, 2,225 behavioral health visits, 15,378 ophthalmology visits at beetham eye institute, 9871 diabetes education visits, 7,426 pediatric visits, 1,579 nephrology visits. additionally, jdc performed 270 eye surgeries.
Revenue declined from $101.0M (FY2013) to $71.6M (FY2023) across 11 reported years.
Financial snapshot
Operating margin
-14.0%
Spent more than it raised in the latest fiscal year.
Total assets
$176.8M
Total liabilities
$16.2M
Net assets
$160.6M
Salaries & benefits
$29.0M
35% of expenses
Board members
14
10 independent
| Fiscal year | Revenue | Expenses | Net assets | Total assets | Form |
|---|---|---|---|---|---|
| 2023 | $71,591,609▼3.5% | $81,626,334▼1.4% | $160,608,284▲4.3% | $176,840,438▲6.5% | 990 |
| 2022 | $74,197,360▼44.7% | $82,769,482▼15.6% | $154,014,521▲5.4% | $166,005,908▲4.7% | 990 |
| 2021 | $134,166,466▲64.0% | $98,047,633▲8.4% | $146,105,200▲77.1% | $158,601,430▲32.4% | 990 |
| 2020 | $81,813,666▲6.3% | $90,420,592▼6.3% | $82,507,784▲5.5% | $119,817,710▲11.4% | 990 |
| 2019 | $76,953,905▼4.0% | $96,451,661▲1.8% | $78,228,399▼16.6% | $107,556,453▼7.7% | 990 |
| 2018 | $80,200,703▼18.4% | $94,714,085▲3.2% | $93,755,336▼13.9% | $116,544,681▼10.3% | 990 |
| 2017 | $98,325,080▲11.7% | $91,783,272▲3.7% | $108,867,829▲13.3% | $129,902,651▲6.6% | 990 |
| 2016 | $88,049,280▲3.4% | $88,501,958▼4.9% | $96,100,424▼0.3% | $121,882,330▼5.1% | 990 |
| 2015 | $85,159,175▲1.7% | $93,080,038▼2.8% | $96,393,088▼3.8% | $128,407,040▼4.6% | 990 |
| 2014 | $83,768,922▼17.0% | $95,799,796▲0.1% | $100,177,124▼13.5% | $134,552,270▼6.7% | 990 |
| 2013 | $100,951,725 | $95,699,704▲3.3% | $115,834,374▲5.4% | $144,264,386▲5.2% | 990 |
| 2012 | — | $92,662,914▲3.0% | $109,889,799▲4.0% | $137,096,256▲0.9% | 990 |
| 2011 | — | $89,954,142▲5.3% | $105,706,842▲12.1% | $135,879,420▲6.4% | 990 |
| 2010 | — | $85,455,938▼11.3% | $94,317,899▼6.1% | $127,648,830▼6.2% | 990 |
| 2009 | — | $96,356,934 | $100,480,038 | $136,074,590 | 990 |
Original Form 990 PDFs (the Form column) are served by ProPublica Nonprofit Explorer, as filed with the IRS. Create a free account to download the CSV report.
Highest-paid: Herman Md Phd Roberta — $919,763 (1.13% of total expenses)
| Name | Title | Hours/week | Compensation |
|---|---|---|---|
| Herman Md Phd Roberta | President & Trustee (ex-officio) | 55 | $919,763 |
| King Md George L | Ttee (ex-off); Chief Scientific Off | 55 | $431,435 |
| Kahn Md Ronald C | Chief Academic Officer | 55 | $412,111 |
| Sun Md Mph Jennifer K | Chief, Center Eye Research & Trials | 55 | $398,845 |
| Aiello Phd Lloyd-paul | Former Vice President, Opthamology | 0 | $388,625 |
| Lit Susan | Chief Operating Officer | 55 | $324,547 |
| Sharuk Md George S | Ophthalmologist | 55 | $315,829 |
| Larrabee Md Joan | Phys, Endocrine/diabetes/metabolism | 55 | $313,047 |
| Halprin Md Elizabeth | Section Chief, Adult Diabetes | 55 | $303,671 |
| Hamdy Md Mph Osama | Phys, Endocrine/diabetes/metabolism | 55 | $301,429 |
| Mehta Md Sanjeev | Ttee & Svp, Cmo, Cmio, Chf Qual Off | 55 | $288,244 |
| Buckley Esq Maria D | Former Clerk, General Counsel | 0 | $231,268 |
| Bhogadi Satish | Asst Treas (ex-off) & Assistant Cfo | 55 | $220,276 |
| Abbrecht Todd | Trustee | 1 | — |
| Armstrong Esq Emily | Asst Clerk (div Vp Dep Gc Bos, Bilh) | 1 | — |
| Devlin Michael K | Trustee | 1 | — |
| Enright Ryan | Trustee | 1 | — |
| Healy Peter | Ttee (exo) (div Pres, Metro Boston) | 1 | — |
| Katz Esq Jamie | Clerk (ex-off); General Counsel Bilh | 1 | — |
| Moses Md Alan | Trustee | 1 | — |
| Contractor | Services | Paid |
|---|---|---|
| Brigham & Women's Hospital | Research | $1,387,330 |
| Fisher Scientific | Research | $957,460 |
| Jackson Laboratory | Research | $524,480 |
| Charles River Laboratories | Research | $452,340 |
| Platformq Health Education LLC | Digital Education Services | $394,180 |
239 grants to Joslin Diabetes Center Inc totaling $53.6M, reported by foundations on their Schedule I filings — showing the 15 most recent.
| Grantmaker | Purpose | Year | Amount |
|---|---|---|---|
| Breakthrough T1d | T1d research | 2024 | $2,565,662 |
| Raymond James Charitable Endowment Fund | General support | 2024 | $254,000 |
| American Heart Association Inc | Research | 2024 | $156,640 |
| Gs Donor Advised Philanthropy Fund For Wealth Management Inc | Medical / public services | 2024 | $105,000 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $70,000 |
| Impactassets Inc | General support | 2024 | $50,000 |
| American Online Giving Foundation Inc | General support | 2024 | $44,121 |
| Community Foundation For Greater Buffalo Inc | Charitable support. any restrictions have been communicated to the grantee. | 2024 | $31,641 |
| Morgan Stanley Global Impact Funding Trust Inc | Unrestricted general support | 2024 | $5,000 |
| Breakthrough T1d | T1d research | 2023 | $2,499,700 |
| Broad Institute Inc | Research | 2023 | $625,859 |
| Fidelity Investments Charitable Gift Fund | For grant recipient's exempt purposes | 2023 | $507,629 |
| Raymond James Charitable Endowment Fund | General support | 2023 | $502,500 |
| Beth Israel Deaconess Medical Center Inc | Research subcontract | 2023 | $308,760 |
| Boston Medical Center Corporation | Subaward | 2023 | $219,545 |
16 grants totaling $9.6M in FY2023 — showing the 15 largest. All grants made by Joslin Diabetes Center Inc →
| Recipient | Purpose | Amount |
|---|---|---|
| Joslin Clinic Inc | Program support | $7,641,661 |
| Mass General Brigham Incorporated | Research-subaward | $515,148 |
| The Board of Trustees of the Leland Stanford Junior University | Research-subaward | $395,951 |
| Regents of the University of Michigan | Research-subaward | $281,587 |
| Mass General Brigham Incorporated | Research-subaward | $221,377 |
| Childrens Hospital Corporation | Research-subaward | $183,117 |
| Jackson Laboratory | Research-subaward | $79,372 |
| Board of the University of Alabama | Research-subaward | $79,144 |
| Massachusetts Institute of Technology | Research-subaward | $48,134 |
| Beth Israel Lahey Health Inc Hcsr | Research-subaward | $30,420 |
| University of Washington | Research-subaward | $29,990 |
| President and Fellows of Harvard College | Research-subaward | $25,246 |
| Trustees of the University of Pennsylvania | Research-subaward | $21,217 |
| Regents of Univ of Minnesota | Research-subaward | $18,764 |
| Umass Medical School | Research-subaward | $16,205 |
Explore more
Data for Joslin Diabetes Center Inc (EIN 04-2203836) comes from the IRS Business Master File and e-filed Form 990 returns, via CharityIndex. Figures reflect what the organization reported to the IRS for each fiscal year.